0001213900-26-038762.txt : 20260402 0001213900-26-038762.hdr.sgml : 20260402 20260401202431 ACCESSION NUMBER: 0001213900-26-038762 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260402 DATE AS OF CHANGE: 20260401 EFFECTIVENESS DATE: 20260402 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ATED Therapeutics Ltd. CENTRAL INDEX KEY: 0002114239 ORGANIZATION NAME: EIN: 333599587 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-578816 FILM NUMBER: 26830250 BUSINESS ADDRESS: STREET 1: ONE SOUND SHORE DRIVE STREET 2: SUITE 103 CITY: GREENWICH STATE: CT ZIP: 06830 BUSINESS PHONE: 2035696825 MAIL ADDRESS: STREET 1: ONE SOUND SHORE DRIVE STREET 2: SUITE 103 CITY: GREENWICH STATE: CT ZIP: 06830 D 1 primary_doc.xml X0708 D LIVE 0002114239 ATED Therapeutics Ltd. ONE SOUND SHORE DRIVE SUITE 103 GREENWICH CT CONNECTICUT 06830 (203) 569-6825 ISRAEL None None Corporation true 2022 Jeff R. Swarz One Sound Shore Drive Suite 103 Greenwich CT CONNECTICUT 06830 Executive Officer Director Joseph Chiarelli One Sound Shore Drive Suite 103 Greenwich CT CONNECTICUT 06830 Executive Officer Director Other Health Care Decline to Disclose 06b false 2024-10-24 false true true false 25000 670000 670000 0 false 13 0 0 0 While no offering proceeds are set aside for payments to the named officers or directors, it is possible that some proceeds to be used as working capital will be used indirectly for paying salaries to employees including executive officers. false ATED Therapeutics Ltd. /s/ Jeff R. Swarz Jeff R. Swarz Chief Executive Officer 2026-04-01